Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis
2025 · Nature Communications · 9 citations
https://doi.org/10.1038/s41467-025-58190-x
C
Carlos E Ruiz-Gonzalez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
13
Citations
2
h-index
0
i10-index
Carlos E Ruiz-Gonzalez is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Infectious Diseases and Tuberculosis & Antifungal resistance and susceptibility. The author has an h-index of 2, co-authored 8 publications.
Papers by this author
works18F-Fluorodeoxysorbitol PET for noninvasive detection of invasive mold infections: preclinical and first-in-human studies
2025 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-025-61700-6
Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis
2026 · The Journal of Infectious Diseases · 0 citations
https://doi.org/10.1093/infdis/jiag123
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat